AwardedAwarded 1 April 2026
Cyres colposcopy and cytology reporting QA license for 26/27 + 1
NHS England · NHS and health
In brief
NHS England awarded healthcare work to Cyres Limited on 1 April 2026.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
A licence for the Cinergy QA module, which links Cyres Cytology and Cyres Colposcopy systems to provide end‑to‑end reporting and enable electronic submission of QA and KC dataset returns for the cervical screening programme.
Who is the supplier?
Cyres – the sole provider of the Cinergy system. No alternative suppliers or frameworks exist, so a Single Tender Action (STA) is the only viable route.
Why is it important?
Cinergy is the national system used by cervical screening laboratories and colposcopy clinics. SQAS requires access to review data, monitor performance, and quality assure the NHSCSP. Without Cinergy, SQAS cannot carry out statutory QA functions, risking inconsistent service quality and patient safety.
What are the risks if we do not purchase this?
SQAS unable to quality assure cervical screening services
Increased risk of avoidable cervical cancer due to lack of oversight
Sub‑optimal patient care and variation in
Who won
| Winner | Value | Dates |
|---|---|---|
| Cyres Limited | £53,663 | 1 April 2026 to 31 March 2027 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Contract details notice · UK7, notice 033674-2026
About the buyer
Similar open tenders
All open healthcare tenders- £7mestimated
- £82kestimated
- Value not stated
- Value not stated
- Value not stated
From notice 033674-2026 on Find a Tender, first published 14 April 2026. We last checked for changes on 28 September 2026.